Evidence map›Paper›PMID 31691018›Full record

Trial reportEuropean journal of nutrition2020

Acute p-synephrine ingestion increases whole-body fat oxidation during 1-h of cycling at Fatmax.

Jorge Gutiérrez-Hellín, Carlos Ruiz-Moreno, Juan Del Coso

Open access · greenAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Effect ofNutrients · 2022
    Trial
  5. Trial
  6. Review
  7. CitrusNutrients · 2024
    Article
  8. Molecules (Basel, Switzerland) · 2023
    Article
  9. Review
  10. Review
  11. Effects ofNutrients · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Jorge Gutiérrez-HellínExercise Physiology Laboratory, Camilo José Cela University, Madrid, Spain.
Carlos Ruiz-MorenoExercise Physiology Laboratory, Camilo José Cela University, Madrid, Spain.
Juan Del CosoCentre for Sport Studies, Universidad Rey Juan Carlos, Fuenlabrada, Spain. juan.delcoso@urjc.es.ORCID http://orcid.org/0000-0002-5785-984X
Camilo José Cela University · ESUniversidad Francisco de Vitoria · ESUniversidad Rey Juan Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposep-Synephrine, the principal alkaloid of bitter orange (Citrus aurantium), is widely used in dietary supplements for weight loss due to its purported effect of increasing fat oxidation. However, there is a paucity of scientific information about its effectiveness in enhancing fat oxidation during exercise. The aim of this investigation was to determine the effect of an acute dose of p-synephrine on substrate oxidation during prolonged and constant intensity exercise.

methodsIn a double-blind and randomized experiment, 14 healthy subjects performed two acute experimental trials after ingesting either p-synephrine (3 mg kg

resultsIn comparison to the placebo, energy expenditure during 1 h of cycling remained unchanged with p-synephrine (698 ± 129 vs. 686 ± 123 kcal, P = 0.08). However, p-synephrine increased whole-body fat oxidation (33.6 ± 10.4 vs. 37.3 ± 9.8 g, P < 0.01) while also reducing carbohydrate oxidation (99.5 ± 30.4 vs. 85.0 ± 28.4 g, P < 0.01). However, the magnitude of the shift on substrate oxidation induced by p-synephrine was small.

conclusionAcute ingestion of p-synephrine augments fat oxidation during prolonged and constant-intensity exercise.

Indexed as

Adipose TissueAdultBicyclingCitrusEatingEnergy MetabolismExerciseHumansOxidation-ReductionSynephrineSynephrineBitter orangeCitrus aurantiumExerciseMaximal fat oxidationNutrition supplement

Identifiers

PMID31691018
OpenAlexW2982750097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.